兽用辅料市场- 依产品类型（黏合剂、崩解剂、乳化剂、填充剂）、配方（口服、注射）、动物类型（牲畜、伴侣）、应用（药物配方、饲料添加剂、生物製品） 、全球预测2024 - 2032

由于动物药品和保健产品的需求不断增加，预计 2024 年至 2032 年间，兽用辅料市场规模的复合年增长率将超过 3.7%。兽医学和生物技术的不断进步促进了新药物配方的开发，对高品质赋形剂的需求不断增加，以提高药物的稳定性、溶解度和生物利用度。

宠物主人对预防保健重要性和各种兽药供应的认识不断提高，增加了对片剂、胶囊和溶液等剂型配方中赋形剂的需求。此外，新型药物输送技术的出现以及对动物个人化医疗的强烈关注也增加了对具有特定功能的创新产品的需求。例如，2024 年 2 月，率先为狗提供长寿药物的生物技术公司 Loyal 宣布了其药物 LOY-002 的关键临床试验 STAY 研究中第一隻狗的剂量。

兽用辅料产业依产品种类、剂型、动物种类、应用、地区等分类。

根据产品类型，填充剂和稀释剂领域的市场规模在预测期内的复合年增长率将达到 3.8%。这可以归因于它们透过改善剂型的物理特性（例如片剂可压缩性和粉末流动性）来提高生产效率，从而在药物配方中提供越来越多的帮助。此外，它们还具有配方多功能性以及与多种活性药物成分 (API) 的兼容性，使其成为兽药开发中不可或缺的组成部分。

在配方方面，由于注射剂领域的兽用辅料在动物用药中发挥关键作用，预计 2024 年至 2032 年期间兽用辅料市场将出现强劲增长。它们具有快速起效、精确的剂量传递和改善的患者依从性，成为兽医保健专业人员的首选。随着注射药物的需求持续成长，同时也需要赋形剂来增强製剂的稳定性、溶解度和安全性。注射製剂中使用的赋形剂还具有缓衝、张力调节和黏度调节等关键功能，以确保兽药的功效和安全性。

亚太地区兽药辅料产业预计在 2024 年至 2032 年期间将实现 4.3% 的成长率。伴侣动物和牲畜数量的增加推动了对高品质辅料的需求，以支持药物配方的开发。此外，中国、印度和东南亚国家等新兴经济体动物保健产业的快速扩张为辅料製造商和供应商带来了巨大的机会。旨在促进动物健康和福利的政府支持倡议，加上兽医和生物技术的进步，将进一步刺激该区域市场的成长。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 人畜共通传染病数量增加
    • 人们对动物健康的认识不断提高
    • 都市化和畜牧业产业化不断发展
    • 宠物拥有量的增加推动兽医护理需求
    • 政府对兽医护理的支持不断增加
    • 不断成长的研发和程序进步
  • 产业陷阱与挑战
    • 兽药成本高
    • 发展中经济体缺乏获得优质兽医护理的机会
• 成长潜力分析
• 监管环境
• 母公司市场展望
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司矩阵分析
• 公司市占率分析
• 竞争定位矩阵
• 战略仪錶板

第 5 章：市场估计与预测：按产品类型，2018 年 - 2032 年

• 主要趋势
• 黏合剂
• 崩解剂
• 黏度剂
• 填充剂和稀释剂
• 调味剂
• 润滑剂和助流剂
• 乳化剂
• 防腐剂
• 其他产品类型

第 6 章：市场估计与预测：按配方划分，2018 年 - 2032 年

• 主要趋势
• 口服
• 可注射
• 专题
• 其他配方

第 7 章：市场估计与预测：按动物类型，2018 - 2032

• 主要趋势
• 畜牧动物
• 伴侣动物

第 8 章：市场估计与预测：按应用划分，2018 年 - 2032 年

• 主要趋势
• 药物製剂
• 饲料添加剂
• 生物製剂

第 9 章：市场估计与预测：按地区划分，2018 年 - 2032 年

• 主要动向：按地区
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 欧洲其他地区
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 澳洲
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 中东和非洲其他地区

第 10 章：公司简介

• Alchemy Impex.
• Azelis Group
• BASF SE
• Clariant
• Colorcon
• Croda International Plc
• Gattefosse Group
• IOI Oleo GmbH
• JRS Pharma
• Lipoid GmbH
• Seppic
• Synergy API

Veterinary Excipients Market size is estimated to record over 3.7% CAGR between 2024 and 2032, owing to the increasing need for pharmaceuticals and healthcare products for animals. Rising advancements in veterinary medicine and biotechnology have led to the development of new pharmaceutical formulations, creating increasing demand for high-quality excipients to enhance drug stability, solubility, and bioavailability.

The growing awareness among pet owners regarding the importance of preventive care and the availability of a wide range of veterinary pharmaceuticals has increased the demand for excipients in the formulation of dosage forms, such as tablets, capsules, and solutions. Additionally, the emergence of novel drug delivery technologies and the strong focus on personalized medicine for animals are contributing to the demand for innovative product with specific functionalities. For instance, in February 2024, Loyal, a biotech company that pioneered longevity drugs for dogs, announced the dosage of first dog in its STAY study, the pivotal clinical trial for its drug LOY-002.

The veterinary excipients industry is classified into product type, formulation, animal type, application, and region.

Based on product type, the market size from the fillers and diluents segment will witness 3.8% CAGR in the forecast period. This can be ascribed to their rising assistance in pharmaceutical formulations by improving the physical properties of dosage forms, such as tablet compressibility and powder flowability for enhancing manufacturing efficiency. Moreover, they offer formulation versatility and compatibility with a wide range of active pharmaceutical ingredients (APIs), making them indispensable components in veterinary drug development.

In terms of formulation, the veterinary excipients market from the injectable segment is projected to register strong growth between 2024 and 2032, due to their pivotal role in the administration of pharmaceuticals to animals. They offer rapid onset of action, precise dosage delivery, and improved patient compliance, emerging as preferred choice for veterinary healthcare professionals. As the demand for injectable pharmaceuticals continues to rise, there is a parallel need for excipients to enhance formulation stability, solubility, and safety. Excipients used in injectable formulations also serve critical functions like buffering, tonicity adjustment, and viscosity modification for ensuring the efficacy and safety of veterinary drugs.

Asia Pacific veterinary excipients industry is slated to record 4.3% growth rate during 2024-2032. The rising population of companion animals and livestock is fueling the need for high-quality excipients to support pharmaceutical formulation development. Furthermore, the rapid expansion of the animal health industry in emerging economies, such as China, India, and Southeast Asian countries is presenting significant opportunities for excipient manufacturers and suppliers. Supportive government initiatives aimed at promoting animal health and welfare, coupled with advancements in veterinary medicine and biotechnology, will further stimulate the regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Base estimates & calculations
• 1.3 Data validation
• 1.4 Forecast parameters
• 1.5 Data sources
  • 1.5.1 Primary
  • 1.5.2 Secondary
    • 1.5.2.1 Paid sources
    • 1.5.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Industry 360-degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increase in the number of zoonotic diseases
    • 3.2.1.2 Rising awareness about animal health
    • 3.2.1.3 Growing urbanization and industrialization of livestock farming
    • 3.2.1.4 Increasing pet ownership propels veterinary care demand
    • 3.2.1.5 Growing government support on veterinary care
    • 3.2.1.6 Rising R&D and procedural advancements
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of veterinary medicines
    • 3.2.2.2 Lack of access to quality veterinary care in developing economies
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Parent market outlook
• 3.6 Porter's analysis
  • 3.6.1 Supplier power
  • 3.6.2 Buyer power
  • 3.6.3 Threat of new entrants
  • 3.6.4 Threat of substitutes
  • 3.6.5 Industry rivalry
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Binders
• 5.3 Disintegrants
• 5.4 Viscosity agents
• 5.5 Fillers and diluents
• 5.6 Flavoring agents
• 5.7 Lubricants and glidants
• 5.8 Emulsifiers
• 5.9 Preservatives
• 5.10 Other product types

Chapter 6 Market Estimates and Forecast, By Formulation, 2018 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Oral
• 6.3 Injectable
• 6.4 Topical
• 6.5 Other formulations

Chapter 7 Market Estimates and Forecast, By Animal Type, 2018 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Livestock animals
• 7.3 Companion animals

Chapter 8 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Drug formulation
• 8.3 Feed additives
• 8.4 Biologics

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

• 9.1 Key trends, by region
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Alchemy Impex.
• 10.2 Azelis Group
• 10.3 BASF SE
• 10.4 Clariant
• 10.5 Colorcon
• 10.6 Croda International Plc
• 10.7 Gattefosse Group
• 10.8 IOI Oleo GmbH
• 10.9 JRS Pharma
• 10.10 Lipoid GmbH
• 10.11 Seppic
• 10.12 Synergy API